“…Previously, we have used PPI mapping to gain insight into a variety of different disease areas, including cancer 26,27 , infectious diseases 35,36,38–40 , neurodegeneration 34,148,149 and heart disease 30,32 In this study, we built a PPI map to study autism, the largest such dataset focused on a neuropsychiatric disorder, which can be used as a resource for the identification of ASD biomarkers and therapeutic targets. Importantly, in this study, we describe a pipeline that combines the PPI data (wild-type and mutant) with AF2, which allowed us to narrow in on specific interaction interfaces regulated by individual mutations that we analyzed in greater detail using a suite of tools including CRISPR-based genetics, stem cell differentiation and organoid generation.…”